Project duration: 3 Years
Project's focus area: Reducing maternal mortality after home births beyond reach of clinics and government health services
|
|
|
|
Each year, more than 340,000 women die in pregnancy and childbirth. 99% of these deaths are in developing countries and hemorrhage is the most common cause worldwide. Bleeding can be controlled in a clinic, but our projects are the first to show traditional midwives can save a woman’s life in her home, where most births take place. This is also where most maternal deaths occur in the developing world--well beyond the reach of hospitals and government health services.
|
|
|
|
We support demonstration studies with traditional midwives; co-sponsor government policy meetings; train doctors and midwives to use misoprostol; and develop market distribution for the drug to be available in pharmacies & clinics nationwide |
|
|
|
The project is uniquely scalable and sustainable. With this drug, traditional midwives get their first effective technology to reduce maternal deaths. Low-cost distribution will ensure widespread access. |
|
|
“My eldest daughter died of postpartum hemorrhage four years ago. In this project we are saving women’s lives with misoprostol. If we had had this earlier, we would have saved her life too.”
- Marguam, traditional midwife trained in our study
|
Amy Grossman,
Director, Communications and Development
Venture Strategies Innovations
2401 East Katella Avenue, Suite 400
Anaheim, California 92806
United States
714-221-2040
|
|
|
|
|
